Home
Strategy
Strategy Overview
Venture Strategy
Credit Strategy
Public Equities Strategy
Co-Investments
Portfolio
Team
Careers
News
Contact
Investor Login
OUR Portfolio
We focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, and work closely with each portfolio company to build and grow the business from inception to exit.
explore our portfolio
EXPLORE OUR PORTFOLIO
Exited in 2019
IPO in 2021
IPO in 2020
Exited in 2022
Exited in 2021
Exited in 2022
IPO in 2021
IPO in 2021
IPO in 2021
Exited in 2020